• AMPLIRUN® ZIKA VIRUS
    RNA CONTROL

    Guarantee the quality of
    your molecular assays


  • VirClia®
    Chemiluminescence in Monotest.
    The perfect combination for infectious serology.


  • Speed-oligo®
    New product design for an affordable,
    automated and contamination free protocol


  • Respiratory virus testing
    The complete solution for respiratory virus testing;
    screening and identification


AACC 2016

Vircell will be attending the largest dedicated clinical laboratory meeting in the world, the AACC’s Annual Meeting and Clinical Lab Expo. We would be pleased to welcome you at our stand!

Philadelphia, August 2-4, 2016, Stand #417

More information

Development and production of diagnostic reagents for human infectious diseases

Vircell is a biotechnology company specialized in the development and production of ready to use reagents for human infectious diseases. We are present in laboratories of more than 80 countries worldwide on five continents. Vircell offers more than 400 references for the detection of bacteria, viruses, parasites and fungi by means of different techniques: ELISA, chemiluminescence, direct and indirect immunofluorescence, immunocapture agglutination, cell culture and Molecular Biology (oligochromatography and PCR controls).

Distributors

Vircell is present in laboratories of more than 80 countries worldwide. International Sales constitute one of the major sources of income for the company thanks to the constant work of our commercial team, who has a deep knowledge of the international market. If you need further information on the distribution of our products in your country, do not hesitate to contact us.

More information
29 April 2016 General Product Training with our distributors from Germany and Lebanon This week we had the pleasure of welcoming our distributors from Germany (Bestbion) and Lebanon ...
02 August 2016 AACC 2016 For another year,  Vircell will be attending the largest dedicated clinical laboratory meeting in the ...

Newsletter

Sign up for our newsletter and you will receive our latest news in your e-mail